3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Endometrial Neoplasms
3
Postoperative Complications
2
Ovarian Neoplasms
2
Lymphedema
2
Lymphatic Metastasis
2
Breast Neoplasms
2
Vulvar Neoplasms
1
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urologic Neoplasms
1
Thyroid Cancer, Papillary
1
Prostatic Neoplasms
1
Platelet Glycoprotein IV Deficiency
1
Parotid Neoplasms
1
Neoplasms
1
Neoplasm Metastasis
1
Lung Neoplasms
1
Facies
1
Esophageal Squamous Cell Carcinoma
1
Esophageal Neoplasms
1
Early Stage Endometrial Cancer
1
Cholangiocarcinoma
1
Carcinoma, Transitional Cell
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Hepatocellular
1
Interventions
Surveys and Questionnaires
5
Pemetrexed
3
Paclitaxel
3
Gemcitabine
3
Docetaxel
3
Brachytherapy
3
pembrolizumab
2
Topotecan
2
Saline Solution
2
Radiotherapy
2
Radiation
2
FANG vaccine
2
Everolimus
2
Doxorubicin
2
Cisplatin
2
Carboplatin
2
CP protocol
2
temsirolimus
1
selinexor
1
osimertinib
1
niraparib
1
fosaprepitant
1
ferumoxtran-10
1
ferrous fumarate
1
durvalumab
1
cobimetinib
1
atezolizumab
1
alovudine
1
Vitamin D
1
Uterine Artery Embolization
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Uterine Neoplasms
×
Lymph Node Excision
×
Clear all
NCT02115477
2019-10-25
LASEC
University Hospital, Linkoeping
Completed
262 enrolled